(Q38209191)

31 August 2017

title

CR1 in Alzheimer's disease (English)

1 reference

31 August 2017

0 references

Jin-Tai Yu

2

0 references

Lan Tan

series ordinal

6

object named as

Lan Tan

1 reference

31 August 2017

3

Teng Jiang

1 reference

31 August 2017

Xi-Chen Zhu

1

1 reference

31 August 2017

Ping Wang

series ordinal

4

1 reference

31 August 2017

Lei Cao

series ordinal

5

1 reference

31 August 2017

publication date

4 May 2014

1 reference

31 August 2017

published in

Molecular Neurobiology

1 reference

31 August 2017

volume

51

1 reference

31 August 2017

issue

2

1 reference

31 August 2017

page(s)

753-765

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-014-8723-8

31 August 2017

exact match

0 references

cites work

Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

The significance of neuroinflammation in understanding Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Replication of CLU, CR1, and PICALM associations with alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genetic variation at CR1 increases risk of cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Complement Receptor 1: disease associations and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Structural and functional correlation of the human complement receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Knops blood group polymorphism and susceptibility to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Structure-function relationships of complement receptor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Implication of Complement System and its Regulators in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Neuronal death in Alzheimer's disease and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Plaque complement activation and cognitive loss in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Role of complement in neurodegeneration and neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

A previously undescribed intron and extensive 5' upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Association of GWAS top hits with late-onset Alzheimer disease in Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Cerebral amyloid angiopathy pathology and cognitive domains in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genetic variation and neuroimaging measures in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

CR1 is associated with amyloid plaque burden and age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

CR1 genotype is associated with entorhinal cortex volume in young healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Systemic catabolism of Alzheimer's Abeta40 and Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Blockage of CR1 prevents activation of rodent microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Neuroscience. Brain under surveillance: the microglia patrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Complement-mediated phagocytosis--the role of Syk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Complement and innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Soluble form of complement C3b/C4b receptor (CR1) results from a proteolytic cleavage in the C-terminal region of CR1 transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Deciphering complement receptor type 1 interactions with recognition proteins of the lectin complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8723-8

Novel disease-modifying therapies for Alzheimer's disease

21 January 2018

1 reference

12 December 2020

C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion

1 reference

12 December 2020

Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.

1 reference

12 December 2020

Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population.

1 reference

12 December 2020

A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32

1 reference

12 December 2020

Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects

1 reference

12 December 2020

Inflammatory signals induce neurotrophin expression in human microglial cells

1 reference

12 December 2020

Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.

1 reference

12 December 2020

Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome.

1 reference

12 December 2020

Structure-function analysis of the active sites of complement receptor type 1

1 reference

12 December 2020

Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma

1 reference

12 December 2020

Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes

1 reference

12 December 2020

Genetic complexity of Alzheimer's disease: successes and challenges.

1 reference

12 December 2020

Missense variants in CR1 are associated with increased risk of Alzheimer' disease in Han Chinese

1 reference

12 December 2020

CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease.

1 reference

12 December 2020

Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups

1 reference

12 December 2020

Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets

1 reference

12 December 2020

Biomarkers for microglial activation in Alzheimer's disease

1 reference

12 December 2020

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

12 December 2020

The Comparison of the Podocyte Expression of Synaptopodin, CR1 and Neprilysin in Human Glomerulonephritis: Could the Expression of CR1 be Clinically Relevant?

1 reference

12 December 2020

Genetic and structural polymorphism of complement receptor 1 in normal Indian subjects

1 reference

12 December 2020

Peripheral nerve CR1 express in situ cofactor activity for degradation of C3b

1 reference

12 December 2020

Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma

1 reference

12 December 2020

10.1007/S12035-014-8723-8

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1000282975

0 references

1 reference